General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Elsevier(MODEST), cardiol therapeutics(MODEST), Kiniksa(SIGNIFICANT), ventyx(NONE), Wolters Kluwer(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Kiniksa(NONE), ventyx(NONE)

View Full Disclosure